Emesis and mucositis caused by chemotherapy in patients with breast or lung cancer.
Conditions
Interventions
The study will be carried out in the oncology department of Botucatu State Hospital and home visits to patients in the cities belonging to the Polo Cuesta, which comprises 13 cities: Anhembi, Areiópol
Device
Other
G07.203.100.975
E02.258
Sponsors
Departamento de Enfermagem da Universidade Estadual de São Paulo
Universidade Estadual de São Paulo
Departamento de Enfermagem da Universidade Estadual de São Paulo
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Over 18 years of age;both genders;carrier of breast or lung cancer;being in adjuvant or neoadjuvant chemotherapeutic treatment;being the first chemotherapy treatment performed;to be performing the first 4 cycles of chemotherapy in the State Hospital of Botucatu.
Exclusion criteria
Exclusion criteria: Patients in palliative care;patients refuse to participate in the research;who not in the first 4 cycles of chemotherapy;patient with recurrence of breast and lung cancer;withdrawal of treatment;death.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The management of emesis and mucositis in patients with breast or lung cancer who underwent chemotherapeutic treatment through the use of ginger tea and mouthwash with chamomile tea, respectively. It will be evaluated through the collection of data that is performed by telephone to analyze adherence and decrease the incidence of adverse reactions. It was done 72 hours after the consumption of ginger tea and for evaluation of the effect of the mouthwash with chamomile tea and researcher will contact on the 10th day. At the end of the interventions and data collection, a statistical analysis of the data is performed. | — |
Secondary
| Measure | Time frame |
|---|---|
| Individualized treatment variables may interfere with the study: the impact of interventions according to each type of neoplasm (breast or lung) and the prescribed chemotherapy, personal characteristics of each patient (oral hygiene, oral characteristics or changes prior to chemotherapy treatment , eating habits, pathologies concomitant with carcinoma, parallel therapies). These aspects will be evaluated through oral cavity evaluation and anamnesis, for further comparison of the data and identification of interferences in the study. | — |
Countries
Brazil
Contacts
Public ContactAngela;Angela Martini;Martini
Universidade Estadual de São Paulo;Universidade Estadual de São Paulo
Outcome results
None listed